Target Audience: This activity is designed for Nurses, Pharmacists, PAs, Social Workers, Physicians, and the Healthcare Team. This activity is accredited for Nurses, Pharmacists, PAs, Social Workers, Physicians, and the Healthcare Team.
Module Description: Low back pain is a prevalent issue that presents challenges in its treatment. While opioids are often used to manage low back pain, evidence supporting their long-term effectiveness is limited, and they come with significant adverse effects. This instructional module aims to provide the entire healthcare team with a structured approach to integrating opioids into the management of low back pain. The instructors will stress the significance of incorporating opioid usage within a comprehensive pain management strategy that: 1. Takes into account psychosocial factors contributing to pain; 2. Recognizes that opioids are not the first-line treatment for low back pain and may not be suitable for all patients; 3. Utilizes non-opioid treatment options; 4. Consistently incorporates strategies to minimize risks and reassess patients periodically.
Educational Objectives:
- Evaluate the benefits and harms of opioids in patients with low back pain (LBP).
- Analyze an evidence-based approach to the selection of patients for opioid therapy for LBP.
- Integrate an evidence-based approach to the management of opioids for LBP.
- Apply strategies for mitigating risks associated with opioids.
Continuing Education information:
In support of improving patient care, American Academy of Addiction Psychiatry is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE) and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
Credit Designation Statements
Physicians
American Academy of Addiction Psychiatry designates this enduring material for a maximum of 1.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nurses and Nurse Practitioners
American Academy of Addiction Psychiatry is an approved provider of nursing continuing education through AAAP’s Joint Accreditation provider #4008192. This activity is approved for up to 1.25 CNE credits.
Pharmacists
This activity has been approved for 1.25 hours of pharmacy continuing education credit. The approval numbers issued are Universal Activity Numbers: JA4008192-0000-23-048-H01-P (pharmacy).
PAs
American Academy of Addiction Psychiatry has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.25 AAPA Category 1 CME credits. Approval is valid until 8/29/2026. PAs should only claim credit commensurate with the extent of their participation.
Social Workers
As a Jointly Accredited Organization, American Academy of Addiction Psychiatry (AAAP) is approved to offer social work continuing education by the Association of Social Work Boards (ASWB) Approved Continuing Education (ACE) program. Organizations, not individual courses, are approved under this program. State and provincial regulatory boards have the final authority to determine whether an individual course may be accepted for continuing education credit. AAAP maintains responsibility for this course. Social workers completing this course receive 1.25 continuing education credits.
Other Health Professionals and Other Learners
Participants will receive a certificate stating this program is designated for 1.25 AMA PRA Category 1 Credits™. This credit is accepted by the AANP and the AAPA.
All Learners
This activity was planned by and for the healthcare team, and learners will receive 1.25 Interprofessional Continuing Education credits for learning and change.
